IGC Pharma's total assets for Q4 2025 were $8.75M, a decrease of -3.65% from the previous quarter. IGC total liabilities were $2.42M for the fiscal quarter, a -14.26% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.